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ABSTRACT
Harlequin ichthyosis is an extremely rare congenital genetic disorder. One of the most prominent features is the severe thickening and 
scales of newborn skin covering the whole body surface. Here, we report the case of a 31-year-old woman admitted to the maternity 
emergency unit due to labor pains, with no remarkable history or previous ultrasound examination. A baby boy was born with typical 
findings of harlequin ichthyosis and clinical diagnosis was made. Despite treatment, the newborn died on the third day. The purpose 
of this report is to share our experience in managing this rare case and to increase awareness of the severity of the disease.
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Harlequin ichthyosis (HI) is a rare genetic skin disorder that is the most severe of all congenital ichthyosis [1]. The word ichthyosis itself is derived from the Greek 
word “ichthys” which means fish, referring to the skin with fish-
scale-like appearance [2]. The reported incidence is relatively 
low, occurring 1 in 300,000 live births [1]. However, it poses 
a high rate of natal mortality [3]. Its mode of inheritance is 
autosomal recessive with a 25% chance of recurring in subsequent 
pregnancies [4]. 
There are still few reports on this case with most affected 
neonates not being able to survive beyond the first few days 
of life. To date, there is no definite cure but merely supportive 
treatment in order to prolong a newborn’s life [1,2]. The rationale 
of this case report is to share our experience and comprehensively 
review the proper management of this rare case. Through 
increased awareness, hopefully, better treatment can be provided 
in other health facilities.
CASE REPORT
A 31-year-old woman, 35 weeks gestation with gravida 1, para 
0, live 0, came with labor pains to maternity emergency unit 
at our primary facility hospital. The pregnancy was not due 
to a consanguinous relationship, with no history of previous 
miscarriage. The mother is healthy with no previous history of 
illness or intake of drugs and noted no relevant issues during 
pregnancy. The father is a healthy 35-year-old man with no 
previous history of illness as well. There is no known history 
of genetic anomalies, skin disorders, or any genetic conditions 
inherited in both the paternal and maternal side. Due to low 
socioeconomic status and low education background, she had 
only undergone antenatal check-up once during the beginning 
of pregnancy with a local midwife. She never had any previous 
ultrasound examination performed. 
A caesarean section was done and a baby boy weighing 2600 
grams was delivered. The infant had APGAR scores of 9 at 1 
minute and 9 at 5 minutes. At birth, he was covered with thick 
vernix which on removal revealed layers of widespread yellowish 
scales. Between these scales was fissured skin which was more 
prominent in flexures. Scalp hair was evident; however, the eyes, 
eyebrow, and eyelashes were undeveloped and ectropion was 
present. The infant’s mouth was persistently open with the traction 
of the lips causing eclabium. The nose and ears were hypoplastic 
with undeveloped orifices. Limited body movements were present, 
as all extremities were semi-flexed in a rigid manner (Fig. 1). 
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Figure 1: Showing features of (a) thick white scale and fissure with 
flexion deformity of the hands (b) patent orifice (c) undeveloped 
extremity (d) ectropion and eclabium of the mouth.
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Based on typical findings of the patient’s impaired skin barrier 
function as prominently shown by the hyperkeratoses and scales 
over the whole body surface area, a clinical diagnosis of Harlequin 
ichthyosis was made by a pediatrician. While waiting for referral 
hospital availability, the baby was kept in an incubator at the 
neonatal intensive care unit (NICU). Vital signs were normal with 
vesicular breathing. 
Supportive management was given. The patient was started 
on intravenous fluids and antibiotics, nasogastric feeding, as well 
as continuous positive airway pressure (CPAP). The patient was 
given cefotaxime 150 mg IV twice daily and gentamycin 15 mg 
IV once daily. The skin surface was cleansed with clean gauze 
pads and applied with topical gentamycin cream and vaseline 
petroleum gel every two to three hours. Treatment continued for 
two days with a slight improvement seen where the thick scales 
and creases have slowly shredded (Fig. 2). However, despite our 
efforts, the baby died on the third day of life from respiratory 
distress. The parents were counseled about the condition and 
advised to undergo genetic counseling for future pregnancies. 
DISCUSSION
The first reported case of harlequin ichthyosis was discovered 
on 1750 by Reverend Oliver Hart [4]. The term “harlequin” 
refers to the character named Harlequin from an Italian theater, 
which depicts a person with a chequered costume [2]. Harlequin 
ichthyosis itself is among one of the three subtypes of autosomal 
recessive congenital ichthyoses [5]. The two other types, namely 
congenital ichthyosiform erythroderma and lamellar ichthyosis, 
were less severe than HI [5]. The mortality rate of HI is high and 
approaching 50% [5]. Age of infant’s death may range from day 
one up to day 52 [6]. 
It has been found that HI is caused by an autosomal recessive 
mutation in the ABCA12 gene [2]. Due to the rare nature of this 
disease, no data is available regarding the predilection of HI on 
race and gender. However, a study reported that higher numbers 
are found in cultures with the practice of parental consanguinity 
[2,5]. This is evident by the high incidence in Pakistani and 
Arab population with parents who were first cousins [5]. Further 
analyses found that genetic mutation on the ABCA12 allele was 
higher in those groups [5]. 
A proposed etiology in HI is due to the altered lipid transport 
coming from mutation of the ABCA12 gene on chromosome 2 
[4,7]. This gene plays a critical role in the coding of membrane-
based lipid transporter protein, the lamellar granules [8]. In 
individuals with normal ABCA12, lipids are transported into 
the lamellar granules which will then be secreted into the 
intercellular space to form the lipid layers of epidermal barrier 
[9]. A disruption in this process causes no lipids to be transported 
and secreted, leading to a collapsed epidermal barrier [9]. The 
deformed lipid layers will consequently alter the normal lipid 
composition, leading to impaired differentiation of keratinocytes 
or hyperkeratosis [7]. Disrupted epidermal barrier function will 
also compensate itself by hyperkeratosis, thus making up the 
features of the HI phenotype [9]. With the loss of protective 
epidermal barrier, deposition of scales or dead skin is impaired, 
making it more hyperkeratotic and susceptible to infection [4].
There are very typical clinical features of this disorder. 
Neonates born with HI present with profound hyperkeratotic 
appearance as evident in the thick white scales and deep 
erythematous diamond-shaped scales [4]. The facial region may 
mimic a clown-like appearance with large open mouth, eclabium, 
flattened nose, rigid flexion deformity in the hands and feet, 
and bilateral ectropion [2,10]. Due to the hyperkeratotic skin, 
the nares seem anteverted and ears are lacking retroaural folds 
[5]. Moreover, the hyperkeratotic skin forms a constriction band 
which hinders the chest movement and leads to respiratory failure 
[3], a common cause of death as evident in our case. A study also 
reported that generalized lack of hair growth is present in 64% of 
cases [5]. Although the patient in our case had scalp hair, in other 
cases this was often only limited to occipital region subsequent 
with declining hair margins [8].   
Besides the orofacial manifestations, neonates with HI also 
present with ophthalmological, gastrointestinal, and neurological 
problems, amongst others [6]. Due to the prominent ectropion, 
exposure keratitis and further corneal scarring may develop [9]. 
Regarding the nutrition intake, newborns who were able to survive 
longer were found to be more likely to have chronic constipation, 
gastroesophageal reflux, and growth deficiency [5]. This also 
impairs neurological development, as evident in survivors who 
show significantly delayed developmental milestones [5]. 
Prenatal diagnosis particularly 3-dimension ultrasonography is 
the first step for early diagnosis in the absence of previous history 
[4]. Most of the cases can be diagnosed as early as the 17th week 
of gestation or immediately after birth [8]. Findings on ultrasound 
may reveal typical HI features with an absence of ear, abnormal 
facial dysmorphism, thick skin and limited fetal movement with 
stiff extremities [8]. Other associated findings are intrauterine 
growth restriction, polyhydramnios, and increased echogenicity 
of the amniotic fluid [11]. However, a late phenotypic expression 
may pose a challenge for early diagnosis through ultrasound 
[11]. DNA testing for mutation in ABCA12 gene provides a 
more conclusive aid in diagnosis [8]. Other useful modalities 
include fetal skin biopsy at the 18th week of gestation to look for 
Figure 2: Presentation at day 2 with shredding of the skin.
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abnormal lamellar granules, as well as chorionic villous sampling 
and amniocentesis [1,8].
The principles of treatment involve supportive and 
multidisciplinary management. Newborns are placed in a 
humidified incubator to minimize transcutaneous water loss, 
appropriate infection control with intravenous antibiotics and 
maintenance of intake [12]. The skin surface must be cared for 
with hourly emollient application andtwo hourly eye lubrication 
[13]. In cases where ischemia develops due to constriction 
bands, a definitive surgical escharotomy must be performed to 
release [3]. A study recommended this intervention to avoid the 
complication of ischemic autoamputation [3]. Another case series 
of 45 patients showed that acitretin, an oral retinoid, is proven 
efficient to shed the hyperkeratosis and increase survival [1,5]. 
However, acitretin may not be widely available particularly in 
developing countries.
This severe chronic disease poses a high risk of patients 
developing dehydration, supervening infection as well as 
respiratory failure [2]. Although the prognosis is very poor and 
most affected neonates do not survive more than one week, 
however, survival rate may still depend on the severity of the 
condition [5,12]. It is very crucial for parents to be well informed 
that there is a 25% risk of recurrence in the next offspring, and that 
genetic counseling and prenatal diagnosis are truly necessary [8].
CONCLUSION
There is no definite cure from this congenital disease, but early 
prenatal diagnosis can be made, complications can be prevented 
and managed comprehensively, although certain therapy may 
be limited in developing countries. Harlequin ichthyosis has 
high morbidity and mortality soon after birth. It is important 
to know that even surviving newborns may still develop 
severe complications in the long-term, as well as other delayed 
developmental milestones.
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